Evidence map›Paper›PMID 42656476›Full record

ArticleFrontiers in oncology2026

Hope and hopelessness in the face of ovarian cancer: perspectives from gynecologists.

Karen Rosnes Gissum, Caroline Engen, Sigrun Drageset, Ane Gerda Zahl Eriksson, Ingvild Vistad, Roger Strand, Line Bjørge

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Karen Rosnes GissumCancer Clinic, Haukeland University Hospital, Bergen, Norway.
Caroline EngenNeuro-SysMed, Centre for the Study of the Sciences and the Humanities, Universitetet i Bergen, Bergen, Norway.
Sigrun DragesetDepartment of Health and Caring sciences, Hogskulen pa Vestlandet, Bergen, Norway.
Ane Gerda Zahl ErikssonInstitute of Clinical Medicine, Faculty of Medicine, Universitetet i Oslo, Oslo, Norway.
Ingvild VistadDepartment of Gynaecology and Obstetrics, Sorlandet sykehus HF, Kristiansand, Norway.
Roger StrandCentre for Cancer Biomarkers CCBIO, Centre for the Study of the Sciences and the Humanities, Universitetet i Bergen, Bergen, Norway.
Line BjørgeCancer Clinic, Haukeland University Hospital, Bergen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Effective communication plays a key role in fostering strong relationships between patients and healthcare providers during cancer treatment and care. Women with ovarian cancer live with the illness and disease aspects of the condition, while biomedical knowledge tends to focus on the disease. We aimed to gain an understanding of the patient-provider relationship in ovarian cancer from a gynecologists' perspective. Materials and methods: We collected data using semi-structured interviews and applied a phenomenological approach to data analysis. Results: We conducted individual interviews with nine gynecologists between October 2022 and February 2023. Three distinctive features defined the gynecologists' understanding (1). When interacting with patients, they focused on diagnostic markers and treatment choices, paying more attention to the disease than to holistic well-being (2). The gynecologists' understanding of ovarian cancer was mainly based on medical knowledge rather than on patients' experiences (3). The tragic nature of ovarian cancer led the gynecologists to create emotional distance as a means of self-preservation, while harboring a hope that medical advancements would lead to a cure in the future but acknowledging their feelings of helplessness in treating these patients. Conclusion: Gynecologists understand ovarian cancer from a disease perspective of health. Their role is to maintain the biomedical dimension of condition, upholding patients' hope as well as their own for medical advancement throughout the ovarian cancer trajectory. Furthermore, gynecologists understand their role as constrained by a rigid system that limits their ability to best provide holistic care to patients.

Indexed as

communicationcomprehensiondiseasegynecologistsillnessovarian neoplasm

Identifiers

PMID42656476
PMCPMC13506811

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.